SARS CoV-2 Post-Acute Sequelae research hub

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

This study, called DEFEND, is looking at whether existing medicines, Paxlovid or Veklury, can help prevent serious heart and blood vessel problems in hospitalised adults who have had COVID-19. It's a first step to see if these treatments can reduce lasting health issues from the virus.